Countries Hong Kong
Asians Prioritize Health Span to Boost Retirement Well-being, Reveals Manulife Survey
Survey of 7,000+ people in Asia shows expectation of early retirement, early deterioration in health Concerns about cost of well-being nu...
March 29, 2023 | News
Boan Biotech Announces 2022 Financial Results
Boan Biotech (6955.HK) today announced its 2022 financial results and recent business developments. 2022 business highlights Record high in revenue: In...
March 28, 2023 | News
'Generations Connect' Project aims to help boost the well-being of 10,000 elderly
e-Health Literacy is closely related to the health and well-being of the elderly. Sino Group and the Ng Teng Fong Charitable Foundation, in collaboration w...
March 25, 2023 | News
WuXi Biologics Reports Remarkable 2022 Annual Results
2022 Financial Highlights Revenue: The Group's revenue increased to RMB15,268.7 million with an increase of 48.4% y-o-y. The increase was...
March 23, 2023 | News
3SBio Reports 7.5% YoY Revenue Growth and 25.2% Jump in Profit for 2022
New drugs started to embrace a commercialization wave, and license-out and license-in partnerships geared up. Revenue in 2022 increased by 7.5% year on yea...
March 22, 2023 | News
AXA Mind Health Study reveals more than half of Gen Z in Asia are suffering from poor mental health
While the COVID-19 pandemic has taken a heavy toll on mind health across society, the latest findings from the annual AXA Study of Mind Health and Wel...
March 20, 2023 | News
Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results
Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading genomics and precision oncology company, today announced financial r...
March 15, 2023 | News
Akeso, based in Hong Kong, completes patient enrollment for Phase III clinical trial of Cadonilimab in the treatment of gastric cancer.
Akeso, Inc. (9926.HK) announced that patient enrollment has been completed for its pivotal Phase III clinical trial for cadonilimab (PD-1/CTLA-4 bi-sp...
March 14, 2023 | News
Antengene's ATG-022 Phase I CLINCH Trial for Solid Tumor Treatment Receives IND Approval in China
- Discovered and developed in-house by Antengene's R&D team, ATG-022 is an antibody-drug-conjugate (ADC) targeting the Tumor Assoc...
March 14, 2023 | News
Prenetics Forms Advisory Board for Precision Oncology Strategy
Prenetics Global Limited (NASDAQ: PRE), a leader in genomic and diagnostic testing, is proud to announce the formation of a new Prenetics Scientific Adviso...
March 02, 2023 | News
Keymed and Lepu Biopharma gain global exclusive license for CMG901 from AstraZeneca.
CMG901 is currently in a Phase I clinical trial for the treatment of Claudin 18.2-positive solid tumors. Preliminary results from the Phase 1 trial indicat...
February 24, 2023 | News
Recce Pharmaceuticals Announces RECCE® Trademark Registered in Hong Kong
Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) (the Company), the Company developing a new class of synthetic anti-infectives, today announced that it has ...
February 03, 2023 | News
Sirnaomics Accelerates Clinical Development of STP705 for the Treatment of Non-Melanoma Skin Cancers
Based on positive clinical readouts from a Phase IIb study for isSCC and a Phase II study for BCC, Sirnaomics is formulating a communication package for th...
February 02, 2023 | News
Agilis RoboticsTM Completes New Round of Live Animal Trials with Miniaturized Robotic Instruments for Endoscopic Surgery
Dr. Jason Y.K. Chan, the co-founder of Agilis RoboticsTM , conducted the test with the firm's second-generation device on a live pig specimen and...
January 17, 2023 | News
Most Read
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
